CDC backs FDA’s decision to reduce time between primary series and booster dose of Pfizer’s Covid-19 vaccine

(CNN) — The US Food and Drug Administration on Monday expanded the emergency use authorization for Pfizer’s Covid-19 vaccine boosters to children ages 12 to 15.

The agency also shortened the time needed before receiving a booster shot from at least six months after completion of the initial series to at least five months, for everyone 12 and older.

“Throughout the pandemic, as the virus that causes Covid-19 has continuously evolved, the need for the FDA to quickly adapt has meant using the best available science to make informed decisions with the health and safety of the American public in mind,” FDA Acting Commissioner Dr. Janet Woodcock said in a statement. “With the current wave of the omicron variant, it’s critical that we continue to take effective, life-saving preventative measures such as primary vaccination and boosters, mask wearing and social distancing in order to effectively fight Covid-19.”

Source link


Read Previous

Racial justice leaders call out investors on Jan. 6 anniversary

Read Next

Skyhawks Head Coach Will Miss Regular Season Opener – CBS Atlanta

Leave a Reply

Your email address will not be published. Required fields are marked *